BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23420624)

  • 1. D-amino acid based protein arginine deiminase inhibitors: Synthesis, pharmacokinetics, and in cellulo efficacy.
    Bicker KL; Anguish L; Chumanevich AA; Cameron MD; Cui X; Witalison E; Subramanian V; Zhang X; Chumanevich AP; Hofseth LJ; Coonrod SA; Thompson PR
    ACS Med Chem Lett; 2012 Oct; 3(12):1081-1085. PubMed ID: 23420624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of tetrazole analogs of Cl-amidine as protein arginine deiminase inhibitors.
    Subramanian V; Knight JS; Parelkar S; Anguish L; Coonrod SA; Kaplan MJ; Thompson PR
    J Med Chem; 2015 Feb; 58(3):1337-44. PubMed ID: 25559347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
    Mondal S; Thompson PR
    Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.
    Jones JE; Slack JL; Fang P; Zhang X; Subramanian V; Causey CP; Coonrod SA; Guo M; Thompson PR
    ACS Chem Biol; 2012 Jan; 7(1):160-5. PubMed ID: 22004374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.
    Knuckley B; Causey CP; Jones JE; Bhatia M; Dreyton CJ; Osborne TC; Takahara H; Thompson PR
    Biochemistry; 2010 Jun; 49(23):4852-63. PubMed ID: 20469888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.
    Causey CP; Jones JE; Slack JL; Kamei D; Jones LE; Subramanian V; Knuckley B; Ebrahimi P; Chumanevich AA; Luo Y; Hashimoto H; Sato M; Hofseth LJ; Thompson PR
    J Med Chem; 2011 Oct; 54(19):6919-35. PubMed ID: 21882827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
    Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis.
    Willis VC; Gizinski AM; Banda NK; Causey CP; Knuckley B; Cordova KN; Luo Y; Levitt B; Glogowska M; Chandra P; Kulik L; Robinson WH; Arend WP; Thompson PR; Holers VM
    J Immunol; 2011 Apr; 186(7):4396-404. PubMed ID: 21346230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Selective Inhibitor of Protein Arginine Deiminase 2.
    Muth A; Subramanian V; Beaumont E; Nagar M; Kerry P; McEwan P; Srinath H; Clancy K; Parelkar S; Thompson PR
    J Med Chem; 2017 Apr; 60(7):3198-3211. PubMed ID: 28328217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled Delivery of Pan-PAD-Inhibitor Cl-Amidine Using Poly(3-Hydroxybutyrate) Microspheres.
    Ahmed D; Puthussery H; Basnett P; Knowles JC; Lange S; Roy I
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidylarginine Deiminase Inhibitor Cl-Amidine Attenuates Cornification and Interferes with the Regulation of Autophagy in Reconstructed Human Epidermis.
    Cau L; Takahara H; Thompson PR; Serre G; Méchin MC; Simon M
    J Invest Dermatol; 2019 Sep; 139(9):1889-1897.e4. PubMed ID: 30878672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular targeting of protein arginine deiminases to suppress colitis and prevent colon cancer.
    Witalison EE; Cui X; Causey CP; Thompson PR; Hofseth LJ
    Oncotarget; 2015 Nov; 6(34):36053-62. PubMed ID: 26440311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photochemical Control of Protein Arginine Deiminase (PAD) Activity.
    Mondal S; Parelkar SS; Nagar M; Thompson PR
    ACS Chem Biol; 2018 Apr; 13(4):1057-1065. PubMed ID: 29517899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.
    Luo Y; Arita K; Bhatia M; Knuckley B; Lee YH; Stallcup MR; Sato M; Thompson PR
    Biochemistry; 2006 Oct; 45(39):11727-36. PubMed ID: 17002273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor.
    Chumanevich AA; Causey CP; Knuckley BA; Jones JE; Poudyal D; Chumanevich AP; Davis T; Matesic LE; Thompson PR; Hofseth LJ
    Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G929-38. PubMed ID: 21415415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor.
    Aliko A; Kamińska M; Falkowski K; Bielecka E; Benedyk-Machaczka M; Malicki S; Kozieł J; Wong A; Bryzek D; Kantyka T; Mydel P
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halogen Bonding Increases the Potency and Isozyme Selectivity of Protein Arginine Deiminase 1 Inhibitors.
    Mondal S; Gong X; Zhang X; Salinger AJ; Zheng L; Sen S; Weerapana E; Zhang X; Thompson PR
    Angew Chem Int Ed Engl; 2019 Sep; 58(36):12476-12480. PubMed ID: 31276611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Peptidylarginine Deiminase Inhibitor Cl-Amidine Suppresses Inducible Nitric Oxide Synthase Expression in Dendritic Cells.
    Jang B; Ishigami A; Kim YS; Choi EK
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29077055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrest.
    Cui X; Witalison EE; Chumanevich AP; Chumanevich AA; Poudyal D; Subramanian V; Schetter AJ; Harris CC; Thompson PR; Hofseth LJ
    PLoS One; 2013; 8(1):e53791. PubMed ID: 23308284
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.